跳转至内容
Merck
CN

219426

Cathepsin L Inhibitor II

The Cathepsin L Inhibitor II controls the biological activity of Cathepsin L. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

别名:

Z-FY-CHO

登录 查看组织和合同定价。

选择尺寸


关于此项目

NACRES:
NA.77
UNSPSC Code:
12352200
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

assay

≥95% (HPLC)

form

solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze

color

off-white

solubility

ethanol: 50 mg/mL, DMSO: soluble

shipped in

ambient

storage temp.

−20°C

Quality Level

General description

A potent and selective inhibitor of Cathepsin L (Cat. No. 219402).

Biochem/physiol Actions

Cell permeable: yes
Product does not compete with ATP.
Reversible: no

Packaging

Packaged under inert gas

Other Notes

Woo, J.-T., et al. 1996. Eur. J. Pharmacol. 300, 131.
Z-Phe-Tyr-CHO

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Standard Handling (A)

存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Prashant Gaikwad et al.
microPublication biology, 2022 (2023-01-07)
Several studies have indicated a role for cathepsin L (CTSL) proteolytic activity in the nucleus under distinct cellular conditions, including during differentiation, senescence, and quiescence. Here we show that addition of CTSL inhibitors to a cell lysis buffer prevents the
Stephan Quintin et al.
The Journal of biological chemistry, 299(7), 104912-104912 (2023-06-13)
α-synuclein (αS) is an abundant, neuronal protein that assembles into fibrillar pathological inclusions in a spectrum of neurodegenerative diseases that include Lewy body diseases (LBD) and Multiple System Atrophy (MSA). The cellular and regional distributions of pathological inclusions vary widely

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持